| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/19/2008 | CN101144072A Fixedpoint mutation modified phytase |
| 03/19/2008 | CN101143898A Treatment of allergic conditions by use of IL-21 |
| 03/19/2008 | CN101143897A Labeling technique for 99Tcm-His10-AnnexinV labeling compound and application of the same as developer in detecting cell apoptosis |
| 03/19/2008 | CN101143896A Bacillus subtilis antibiotic peptide fengycin homologue and preparation method thereof |
| 03/19/2008 | CN101143889A High efficiency finished purification method for colibacillus expression recombinant human interleukin-11 |
| 03/19/2008 | CN100375753C Process for the purification of TNF-binding proteins using IMAC |
| 03/18/2008 | US7345229 Insect resistant cotton plants |
| 03/18/2008 | US7345220 Aspartate kinase |
| 03/18/2008 | US7345217 Trangenic heat, freeze, drought and disease resistant plants |
| 03/18/2008 | US7345166 Water soluble biodegradable polymeric photocatalysts |
| 03/18/2008 | US7345160 Photoprotein capable of binding coelenterazine and molecular oxygen, allows for emission of light at longer wavelengths as result of energy transfer; assay for screening HIV-1 protease inhibitors; microanalysis and drug discovery; kits |
| 03/18/2008 | US7345158 Cardiac failure, cardiomegaly, myocarditis, cardiomyopathy, arteriosclerosis, arteriosclerosis obliterans, or ischemic heart disease |
| 03/18/2008 | US7345157 For analyzing the localization or dynamics of a protein in cells, for analyzing a physiologically active substance |
| 03/18/2008 | US7345156 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas |
| 03/18/2008 | US7345154 growth hormone supergene family; prolongs circulating half-lives of protein therapeutics in the body so proteins do not have to be injected frequently; adding cysteine residues to non-essential regions using site-directed mutagenesis; covalently coupling a cysteine-reactive polymer via the added cysteine |
| 03/18/2008 | US7345153 An antibody capable of specifically inhibiting the fusion of an HIV-1 envelope glycoprotein cell with a CD4+ cell without cross reacting with the HIV-1 envelope glycoprotein or CD4 and inhibits infection by strains of HIV-1 |
| 03/18/2008 | US7345150 Albumin-based colloid composition having at least one protected thiol region, methods of making, and methods of use |
| 03/18/2008 | US7345149 growth hormone supergene family; prolongs circulating half-lives of protein therapeutics in the body so proteins do not have to be injected frequently; adding cysteine residues to non-essential regions using site-directed mutagenesis; covalently coupling a cysteine-reactive polymer via the added cysteine |
| 03/18/2008 | US7345148 Human G-protein coupled receptor, HGPRBMY29sv1 polypeptides |
| 03/18/2008 | US7345147 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
| 03/18/2008 | US7345146 PRO1271 Polypeptides |
| 03/18/2008 | US7345145 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/18/2008 | US7345143 Plastid transit peptides |
| 03/18/2008 | US7345081 Azabicyclo-octane inhibitors of IAP |
| 03/18/2008 | US7345026 A part of the coding sequence of the middle glycoprotein of the hepatitis B virus, which has a dna sequence coding for at least one tumor epitope of a tumor antigen inserted |
| 03/18/2008 | US7345022 Anti-fibril peptides |
| 03/18/2008 | US7345020 Macrocyclic peptidomimetic for use in treatment of multiple sclerosis and autoimmune disorders |
| 03/18/2008 | US7345019 Modulation of excitable tissue function by peripherally administered erythropoietin |
| 03/18/2008 | US7345018 Immobilization drug; side effect reduction |
| 03/18/2008 | US7344888 Nucleotide sequences coding viral promoter sequences for use in detection of viral infection in plants; regulatory elements for expression of heterologous genes in cells |
| 03/18/2008 | US7344882 nucleotide sequences that code human transient receptor potential channel polypeptides or fragments; genetic vectors, host cells, antibodies, and recombinant and synthetic methods for producing polypeptides; drug screening; medical diagnosis |
| 03/18/2008 | US7344880 Nucleotide sequences coding polypeptide for use in the treatment of immunological disorders |
| 03/18/2008 | US7344874 Transgenic coryneform for use as bioreactor in fermentation of glutamic acid for use in medicine, foods and animal feeds |
| 03/18/2008 | US7344872 involves engineering a recombinant shuttle vector comprising a nucleic acid cassette encoding prokaryotic green fluorescent protein (GFP) operably linked to regulatory sequences which permit its expression in a host cell |
| 03/18/2008 | US7344870 3-phosphoinositide-dependent protein kinase |
| 03/18/2008 | US7344869 Isolated DNA comprising one or more genes specific for 5S clavam biosynthesis, vectors comprising such DNA and Streptomyces hosts capable of improved clavulanic acid production |
| 03/18/2008 | US7344862 Nucleotide sequences coding polypeptide for use ias diagnostic tool in genetic engineering; proteins that are colored and/or fluorescent, where this feature arises from the interaction of two or more residues of the protein |
| 03/18/2008 | US7344861 Nucleotide sequences coding protein factors for use in identifying modulators for diagnosis, treatment and prevention of cell proliferative, metabolic, inflammatory, nervous system and immune disorders |
| 03/18/2008 | US7344860 Polynucleotide encoding a novel human P2X7 splice variant, HBMYP2X7v |
| 03/18/2008 | US7344859 Chimeric g-protein coupled receptor for use as tool in high throughput assays which screen/identify modulators of sweet taste; artificial sweetners; enhancing consumability/flavor of animal feeds |
| 03/18/2008 | US7344858 Glycosylated human granulocyte colony-stimulating factor (G-CSF) isoform |
| 03/18/2008 | US7344857 Comprises nucleotide sequences coding transcription factor for use as regulatory tools in nervous system development |
| 03/18/2008 | US7344856 Method of controlling cleavage by OmpT protease |
| 03/18/2008 | US7344845 For identifying potential anti-odorants in deodorants, air and carpet fresheners, fabric deodorizers and compositions for camouflaging odor |
| 03/18/2008 | US7344844 Can be used for the treatment of diabetes or for delaying the onset of diabetes |
| 03/18/2008 | US7344838 Gene encoding brain specific membrane protein |
| 03/18/2008 | US7344724 proteins and genes codes, used for medical diagnosis, screening biological targets and as vaccines against gramnegative bacterial infections |
| 03/18/2008 | US7344723 Self-replicating RNA molecule from hepatitis C virus |
| 03/18/2008 | US7344721 Polypeptide for the treatment of cancer and a method for preparation thereof |
| 03/18/2008 | US7344719 Homologous 28-kilodalton immunodominant protein genes of Ehrlichia canis and uses thereof |
| 03/18/2008 | US7344711 Administering an adenovirus defective in its VAI and VAII virus-associated RNAs |
| 03/18/2008 | US7344709 Administering interferon-beta (IFN- beta 9), after failed treatment with interferon- alpha |
| 03/18/2008 | US7344701 For conjugation with biomolecules, drugs, and toxins |
| 03/18/2008 | US7344699 Drug conjugate comprising an erythropoietin receptor ligand and an anticancer agent |
| 03/18/2008 | US7343721 PRO4406 polypeptide |
| 03/18/2008 | CA2448908C Adenovirus protein ix, its domains involved in capsid assembly, transcriptional activity and nuclear reorganization |
| 03/18/2008 | CA2334154C Functionalised polymers of .alpha.-amino acids and the method of preparation thereof |
| 03/18/2008 | CA2320430C Recombinant mistletoe lectins |
| 03/18/2008 | CA2316908C Method of producing elastin, elastin-based biomaterials and tropoelastin materials |
| 03/18/2008 | CA2189145C Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent |
| 03/18/2008 | CA2185043C Monoclonal antibodies recognizing tie-receptor and their use |
| 03/18/2008 | CA2181073C Tissue-specific enhancer active in prostate |
| 03/18/2008 | CA2175490C Methods of analysis and manipulation of dna utilizing mismatch repair systems |
| 03/18/2008 | CA2166102C Redirection of cellular immunity by receptor chimeras |
| 03/18/2008 | CA2154982C Preparation of .alpha.1 antichymotrypsin |
| 03/18/2008 | CA2089735C Ryegrass pollen allergen |
| 03/18/2008 | CA2015060C Novel antibody delivery system for biological response modifiers |
| 03/13/2008 | WO2008031098A1 Binary amino acid libraries for fibronectin type iii polypeptide monobodies |
| 03/13/2008 | WO2008031045A2 Aquaretic and natriuretic polypeptides lacking vasodilatory activity |
| 03/13/2008 | WO2008031009A2 Wnt antagonists and their use in the diagnosis and treatment of wnt-mediated disorders |
| 03/13/2008 | WO2008031004A2 Binding of proanthocyanidins with bacteria and bacterial components |
| 03/13/2008 | WO2008030901A2 Biomarker fragments for the detection of human bnp |
| 03/13/2008 | WO2008030865A1 Assay for antibodies to mycobacterium paratuberculosis |
| 03/13/2008 | WO2008030558A2 Modified human plasma polypeptide or fc scaffolds and their uses |
| 03/13/2008 | WO2008030429A2 Novel haplotype of human t2r receptor ht2r50 and its use in assays for identifying human bitter taste modulators |
| 03/13/2008 | WO2008030367A2 Selective myostatin inhibitors |
| 03/13/2008 | WO2008030122A1 Biomarkers |
| 03/13/2008 | WO2008030076A1 Recovery and purification of b-phycoerythrin produced by porphyridium cruentum using two-aqueous-phase systems and isoelectric precipitation |
| 03/13/2008 | WO2008029807A1 Novel polypeptide having cytotoxicity against cancer, method for screening for the polypeptide, and use of the polypeptide |
| 03/13/2008 | WO2008029138A2 Peptides and methods |
| 03/13/2008 | WO2008028977A2 Serum albumin binding proteins with long half-lives |
| 03/13/2008 | WO2008028939A1 Means and methods for the production of amyloid oligomers |
| 03/13/2008 | WO2008028934A1 Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof |
| 03/13/2008 | WO2008028684A2 Peptides with high affinity for the prolactin receptor |
| 03/13/2008 | WO2008028645A1 Peptides binding the tpo receptor |
| 03/13/2008 | WO2008028535A1 Split-core-particles for the presentation of foreign molecules, especially for vaccine applications, and method for their production |
| 03/13/2008 | WO2008028530A1 Compounds as aptamer-dimers and their uses in diagnosis and therapy |
| 03/13/2008 | WO2008028501A1 Methods for blocking the interaction between nkp80 and its ligand aicl |
| 03/13/2008 | WO2008028251A1 Dna-binding protein, nucleoprotein complex and method of use |
| 03/13/2008 | WO2008028250A1 Therapeutic agents, targets and diagnostics |
| 03/13/2008 | WO2008014426A3 Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells |
| 03/13/2008 | WO2008012066A3 Novel peptide having antimicrobial activity |
| 03/13/2008 | WO2008007960A3 Gainac specific binding molecules and uses thereof |
| 03/13/2008 | WO2007144442A8 P53 fusion proteins without transcription activity, and applications thereof |
| 03/13/2008 | WO2007144342A3 Use of a plastid-lipid associated protein promoter (pap promoter) for heterologous gene expression |
| 03/13/2008 | WO2007138324A3 Materials and complexes for the delivery of biologically-active material to cells |
| 03/13/2008 | WO2007136752A3 Erythropoietin compositions |
| 03/13/2008 | WO2007134303A3 Modified bacteriocins and methods for their use |
| 03/13/2008 | WO2007133623A3 Peptide diagnostic agent for lyme disease |
| 03/13/2008 | WO2007128553A9 Mig12 |